Publications by authors named "Neil A Accortt"

Claim this Profile
R
Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb).
Ran Jin, Adesuwa S Ogbomo, Neil A Accortt, Lincy S Lal, Geetanjali Bishi

Ther Adv Med Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer.
Whitney Rhodes, Richard W DeClue, Neil A Accortt, Ran Jin, Darcie Sandschafer

Future Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for Major Therapeutic Changes to Produce Significant Clinical Response Across a Broad Range of Disease Activity: An Observational Study of US Veterans With Rheumatoid Arthritis.
Brian C Sauer, Wei Chen, Jincheng Shen, Neil A Accortt, David H Collier

Arthritis Care Res (Hoboken)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.
Dimitrios A Pappas, Heather J Litman, Tamara Lesperance, Greg Kricorian, Elaine Karis, Neil A Accortt

Rheumatol Int· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry.
Dimitrios A Pappas, Ying Shan, Tamara Lesperance, Greg Kricorian, Elaine Karis, Neil A Accortt

ACR Open Rheumatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis.
Brian C Sauer, Wei Chen, Yizhe Xu, Jincheng Shen, Neil A Accortt

Arthritis Res Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.
Jie Zhang, Gayathri Sridhar, Charles E Barr, Bernadette Eichelberger, Catherine M Lockhart, Neil A Accortt

J Manag Care Spec Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry.
Dimitrios A Pappas, Sabrina Rebello, Mei Liu, Jennifer Schenfeld, YouFu Li, Neil A Accortt

J Rheumatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting.
Philip J Mease, Neil A Accortt, Sabrina Rebello, Carol J Etzel, Ryan W Harrison

Rheumatol Int· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry.
Jacob R Stever, Grant W Cannon, Chia-Chen Teng, Neil A Accortt, David H Collier

Clin Exp Rheumatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population.
Amy S Paller, Jennifer Schenfeld, Neil A Accortt, Gregory Kricorian

Pediatr Dermatol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
Jeffrey A Sparks, Tamara Lesperance, Neil A Accortt, Daniel H Solomon

Arthritis Care Res (Hoboken)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.
Neil A Accortt, Tamara Lesperance, Mei Liu, Sabrina Rebello, Mona Trivedi

Arthritis Care Res (Hoboken)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.
Neil A Accortt, James B Chung, Machaon Bonafede, Brendan L Limone, David M Mannino

Int J Chron Obstruct Pulmon Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
Helga Radner, Tamara Lesperance, Neil A Accortt, Daniel H Solomon

Arthritis Care Res (Hoboken)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use.
Wendy J Carman, Neil A Accortt, Mary S Anthony, Janet Iles, Cheryl Enger

Pharmacoepidemiol Drug Saf· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.
Neil A Accortt, Jennifer Schenfeld, Eunice Chang, Elya Papoyan, Michael S Broder

Adv Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis.
Jennifer Schenfeld, Jan Iles, Mona Trivedi, Neil A Accortt

Rheumatol Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity.
Brian C Sauer, Chia-Chen Teng, Neil A Accortt, Zachary Burningham, David Collier

Arthritis Res Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Treatment Patterns in Patients with Psoriatic Arthritis Initiating Biologic and Nonbiologic Therapy in a Clinical Registry.
Philip J Mease, Tamara Lesperance, Mei Liu, David H Collier, Marc Mason, Neil A Accortt

J Rheumatol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Neil A Accortt, Machaon M Bonafede, David H Collier, Jan Iles, Jeffrey R Curtis

Arthritis Rheumatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results.
Alexa B Kimball, Kenneth J Rothman, Gregory Kricorian, David Pariser, Paul S Yamauchi, Neil A Accortt

J Am Acad Dermatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.
Brian M Parrett, Neil A Accortt, Rui Li, Amarjit S Dosanjh, Suresh Thummala

Melanoma Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of arterial thrombotic events in inflammatory bowel disease.
Christina Ha, Simon Magowan, Neil A Accortt, Jiajing Chen, Christian D Stone

Am J Gastroenterol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Anne Brecht Francken, Neil A Accortt, Helen M Shaw, Martin Wiener, Seng-jaw Soong

Ann Surg Oncol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis